Gurel A, Armutcu F, Cihan A, Numanoglu K V, Unalacak M
Department of Biochemistry and Clinical Biochemistry, Karaelmas University Faculty of Medicine Zonguldak, Turkey.
Eur Surg Res. 2004 Jul-Aug;36(4):206-9. doi: 10.1159/000078854.
The aim of the present study was to determine the effects of erdosteine, a new antioxidant and anti-inflammatory agent, on lipid peroxidation, neutrophil infiltration, and antioxidant enzyme activities in a rat model of renal ischemia-reperfusion (I/R) injury. Twenty-eight rats were divided into three groups: sham operation, I/R, and I/R plus erdosteine groups. After the experimental procedure, rats were sacrificed and kidneys were removed and prepared for malondialdehyde (MDA) levels, myeloperoxidase (MPO), xanthine oxidase (XO), catalase (CAT) and superoxide dismutase (SOD) activities. MDA level, MPO and XO activities were significantly increased in the I/R group. On the other hand, SOD and CAT activities were found to be decreased in the I/R group compared to the sham group. Pretreatment with erdosteine significantly diminished tissue MDA level, MPO and XO activities. Our data support a role for erdosteine in attenuation in renal damage after I/R injury of the kidney, in part at least by inhibition of neutrophil sequestration and XO activity.
本研究的目的是确定一种新型抗氧化和抗炎药物厄多司坦对肾缺血再灌注(I/R)损伤大鼠模型中脂质过氧化、中性粒细胞浸润及抗氧化酶活性的影响。28只大鼠被分为三组:假手术组、I/R组和I/R加厄多司坦组。实验结束后,处死大鼠并取出肾脏,用于检测丙二醛(MDA)水平、髓过氧化物酶(MPO)、黄嘌呤氧化酶(XO)、过氧化氢酶(CAT)和超氧化物歧化酶(SOD)活性。I/R组的MDA水平、MPO和XO活性显著升高。另一方面,与假手术组相比,I/R组的SOD和CAT活性降低。厄多司坦预处理显著降低了组织MDA水平、MPO和XO活性。我们的数据支持厄多司坦在减轻肾脏I/R损伤后肾损伤中的作用,至少部分是通过抑制中性粒细胞滞留和XO活性实现的。